involves introducing a gene with an anticancer protein called tumor necrosis factor (TNF) into test tube samples of the patient's own cancer cells, which are then reintroduced into the patient.
Overall, the survival rate for gene therapy treatments is quite high, with some treatments showing success rates above 90%. However, the exact percentage can vary depending on the specific genetic disorder being treated, the stage of the disease, and the individual patient's response to the therapy. It is important to consult with a healthcare provider for accurate and up-to-date information on survival rates for specific gene therapy treatments.
maybe. maybe not. Playing with the gods creations is not v safe
Cystic fibrosis is an example of a disease that might be treated using gene therapy. This genetic disorder affects the lungs and digestive system, and gene therapy could potentially be used to correct the underlying genetic mutation that causes the disease.
Yes
at the gene level gene therapy is done and at the the protein level protein therapy is done
It eliminates the undesired gene and replaces it with a unaffected gene
That process is called gene therapy. It involves inserting functional copies of a gene into the cells of a person with a genetic disorder to correct the genetic mutation causing the disorder.
Many of the more commonly occurring disorders, including heart disease, diabetes, and high blood pressure, result from defects in multiple genes making them unlikely candidates for gene therapy using existing technologies.
Gene therapy may not always work due to challenges in delivering the therapeutic gene to the target cells, potential immune responses, difficulty in achieving sustained gene expression, and the complexity of genetic diseases. Additionally, off-target effects, limited understanding of gene function, and ethical concerns surrounding genetic manipulation can also impact the success of gene therapy.
Yes, cystic fibrosis is a candidate for gene therapy. Gene therapy offers the potential to correct the underlying genetic cause of the disease, which is a mutation in the CFTR gene. While there have been some promising developments in gene therapy for cystic fibrosis, further research and clinical trials are needed to fully assess its effectiveness.
With the help of Gene therapy we can replace or supress the cancer gene
in 1989 us approve gene therapy exprement on human